Literature DB >> 8668677

Physicochemical characterization of protein-free low density lipoprotein models and influence of drug loading.

A Gerke1, K Westesen, M H Koch.   

Abstract

PURPOSE: Drug free and drug loaded protein-free low density lipoprotein (LDL) models consisting mainly of phospholipids, cholesterol, cholesterol esters, and triglycerides in ratios found for physiological LDL have been prepared. Their physicochemical characteristics were compared with those of physiological LDL.
METHODS: Different characterization methods were used: photon correlation spectroscopy, transmission electron microscopy, X-ray solution scattering, and 1H nuclear magnetic resonance spectroscopy (NMR).
RESULTS: Particle sizes are highly dependent on the preparation method and in particular on the homogenization conditions. Electron microscopy indicates that the size distributions of model systems are much broader than those of physiological LDL. The X-ray solution scattering patterns of the model systems display a temperature dependent maximum near 3.8 nm similar to that found in the patterns of physiological LDL. NMR indicates a comparable mobility of the lipid molecules in model particles and in physiological LDL. The influence of drug loading is similar to that found earlier for physiological LDL. In particular, the incorporation of the anti-cancer drug WB 4291 seems to have a fluidizing effect on the lipids in the core region of the particles.
CONCLUSIONS: The preparation method of LDL model systems is of crucial importance as only the solvent evaporation method yielded systems in the size range of physiological LDL with acceptable high lipid concentrations. The fluidizing influence of temperature and drug incorporation (WB 4291) may be disadvantage in drug targeting.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8668677     DOI: 10.1023/a:1016069031411

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Structure of serum low-density lipoprotein. I. A solution X-ray scattering study of a hyperlipidemic monkey low-density lipoprotein.

Authors:  V Luzzati; A Tardieu; L P Aggerbeck
Journal:  J Mol Biol       Date:  1979-07-05       Impact factor: 5.469

2.  Molecular packing and fluidity of lipids in human serum low density lipoproteins.

Authors:  P Laggner; G Degovics; K W Müller; O Glatter; O Kratky; G Kostner; A Holasek
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1977-07

3.  Low-density lipoprotein as a carrier of antitumoral drugs: in vivo fate of drug-human low-density lipoprotein complexes in mice.

Authors:  M Masquelier; S Vitols; C Peterson
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

4.  Microemulsions of phospholipids and cholesterol esters. Protein-free models of low density lipoprotein.

Authors:  G S Ginsburg; D M Small; D Atkinson
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

5.  The order-disorder transition of the core cholesteryl esters of human plasma low density lipoprotein. A proton nuclear magnetic resonance study.

Authors:  P A Kroon
Journal:  J Biol Chem       Date:  1981-06-10       Impact factor: 5.157

6.  Thermal transitions in human plasma low density lipoproteins.

Authors:  R J Deckelbaum; G G Shipley; D M Small; R S Lees; P K George
Journal:  Science       Date:  1975-10-24       Impact factor: 47.728

7.  Cholesteryl ester-rich microemulsions: stable protein-free analogs of low density lipoproteins.

Authors:  D P Via; I F Craig; G W Jacobs; W B Van Winkle; S C Charlton; A M Gotto; L C Smith
Journal:  J Lipid Res       Date:  1982-05       Impact factor: 5.922

8.  Increased plasma removal of microemulsions resembling the lipid phase of low-density lipoproteins (LDL) in patients with acute myeloid leukemia: a possible new strategy for the treatment of the disease.

Authors:  R C Maranhão; B Garicochea; E L Silva; P D Llacer; F J Pileggi; D A Chamone
Journal:  Braz J Med Biol Res       Date:  1992       Impact factor: 2.590

9.  Structure and interactions of lipids in human plasma low density lipoproteins.

Authors:  R J Deckelbaum; G G Shipley; D M Small
Journal:  J Biol Chem       Date:  1977-01-25       Impact factor: 5.157

10.  Characterization of native and drug-loaded human low density lipoproteins.

Authors:  K Westesen; A Gerke; M H Koch
Journal:  J Pharm Sci       Date:  1995-02       Impact factor: 3.534

View more
  1 in total

1.  Supercooled smectic nanoparticles: a potential novel carrier system for poorly water soluble drugs.

Authors:  J Kuntsche; K Westesen; M Drechsler; M H J Koch; H Bunjes
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.